Julia Robinson is our clinical and science editor.
A deprescribing network led by two pharmacists will be launched in June 2019 to help address the issue of inappropriate polypharmacy across England and make deprescribing a “normal thing to do”.
Antiplatelet medicines, such as aspirin, appear to be safe and possibly beneficial for patients who have suffered an intracerebral haemorrhagic stroke, results from a clinical trial published in The Lancet suggest.
Many prescribers are concerned about starting discussions with patients on lowering their use of opioids, a medicines optimisation research team from the School of Pharmacy at the University of East Anglia has found.
Recent blog posts
In 2018, our most popular research briefings covered new areas of research that have been particularly topical this year — including medical cannabis, new antibiotics and e-cigarettes — as well as areas that have long been of interest to pharmacists, such as pain management and adherence.
Julia Robinson summarises the pertinent themes discussed during The Salvadore’s Twitter chat held on Wednesday 12 December 2018.
Catch up on this year’s most read clinical trial stories, many of which cover important research into adverse effects of commonly used drugs.